Bone Marrow Transplant Isn’t Only for Cancer—Who Else Needs It
By Dr. Abhijit Giram
Pune, 9th February 2026: Bone marrow transplant (BMT) is often associated with blood cancers such as leukemia or lymphoma. This life-saving treatment is similarly important for a number of non-cancerous blood and immunological problems, even if cancer is still a primary indication. Transplant medicine’s importance has grown thanks to advancements in the field, which now provide curative therapy for illnesses that were previously only treated with lifetime supportive care.
The soft substance found inside bones that produces platelets, white blood cells, and red blood cells is called bone marrow. Normal blood production can be restored by substituting healthy stem cells with sick marrow when this system malfunctions because of inherited, autoimmune, or acquired disorders. This is the idea underlying hematopoietic stem cell transplantation, another name for bone marrow transplantation.
Aplastic anemia, a disorder in which the bone marrow ceases to produce enough blood cells, is one of the most significant non-cancer indications. Patients frequently experience bleeding tendencies, repeated infections, and severe anemia. Instead of long-term reliance on blood transfusions and medicines, bone marrow transplantation provides the potential for a full recovery in younger patients with a qualified donor.
Another significant population that benefits from transplantation is those with inherited blood diseases. Iron overload and organ damage eventually result from conditions like sickle cell disease and thalassemia major, which need regular transfusions starting in early childhood. A successful transplant removes the underlying medical condition and the need for continuous transfusions by substituting healthy stem cells for the damaged marrow.
In some immune deficiency conditions, when the body is unable to adequately fight infections, bone marrow transplants are also employed. Transplantation aids in the reconstruction of a functional immune system in infants with severe combined immunodeficiency (SCID) and other congenital immunological diseases, frequently improving their chances of life.Multiple sclerosis a neurological disorder where immune mediated nerve damage occurs which leads to physical disability. his is a non-hematological condition where bone marrow transplant can offer a cure.
Several meticulously designed processes are involved in the transplant procedure. To inhibit the damaged bone marrow and immune system, the patient first receives conditioning treatment, which may involve radiation or chemotherapy. After that, healthy stem cells are injected intravenously, much like a blood transfusion, from a matched donor’s bone marrow, peripheral blood, or umbilical cord blood. After migrating to the bone marrow spaces, these stem cells progressively start making healthy blood cells.
The post-transplant period is important. Patients are continuously watched for infections, graft-versus-host disease, and transplant rejection. Over the past ten years, results have greatly improved due to improved donor matching methods, sophisticated infection control, and contemporary supportive care.
Today, bone marrow transplants are a definitive treatment for a wide range of significant blood and immunological illnesses in addition to being a cancer therapy. It gives many patients, particularly children and young people, a hope for long-term survival and a healthy life beyond chronic illness with prompt diagnosis, suitable donor selection, and skilled transplant care.
(Dr. Abhijit Giram is Consultant-Haematology, Haemato-oncology & Bone Marrow Transplant at Manipal Hospital, Baner, Pune)
